Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGossamer Bio Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | -$0.23 | -$0.05 | -$0.17 |
| Q2 2026 | 6 | -$0.21 | -$0.05 | -$0.12 |
| Q3 2026 | 3 | -$0.17 | -$0.07 | -$0.11 |
| Q4 2026 | 4 | -$0.13 | -$0.05 | -$0.08 |
| Q1 2027 | 2 | -$0.15 | -$0.06 | -$0.10 |
| Q2 2027 | 2 | -$0.11 | -$0.04 | -$0.07 |
| Q3 2027 | 2 | -$0.02 | -$0.01 | -$0.02 |
| Q4 2027 | 2 | $0.03 | $0.06 | $0.04 |
Gossamer Bio Inc Earnings Date And Information
Gossamer Bio Inc last posted its earnings results on Tuesday, March 17th, 2026. The company reported $-0.21 earnings per share for the quarter, missing analysts' consensus estimates of $-0.2 by $0.01. The company had revenue of 13.80 M for the quarter and had revenue of 48.47 M for the year. Gossamer Bio Inc has generated $-1 earnings per share over the last year ($-0.75 diluted earnings per share) and currently has a price-to-earnings ratio of -0.46. Gossamer Bio Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Gossamer Bio Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/17/2026 | Q4 2025 | -$0.20 | -$0.21 | -0.01 | $7.52 M | $13.80 M |
| 11/05/2025 | Q3 2025 | -$0.19 | -$0.21 | -0.02 | $6.38 M | $13.29 M |
| 08/05/2025 | Q2 2025 | -$0.18 | -$0.17 | 0.01 | $5.41 M | $11.49 M |
| 05/15/2025 | Q1 2025 | -$0.18 | -$0.16 | 0.02 | $4.07 M | $9.89 M |
| 03/13/2025 | Q4 2024 | -$0.17 | -$0.15 | 0.02 | $6.83 M | $9.38 M |
| 11/07/2024 | Q3 2024 | -$0.18 | -$0.14 | 0.04 | $8.53 M | $9.48 M |
| 08/12/2024 | Q2 2024 | $0.23 | $0.22 | -0.01 | $114.29 M | $95.84 M |
| 05/07/2024 | Q1 2024 | -$0.19 | -$0.19 | 0 | N/A | $0 |
| 03/05/2024 | Q4 2023 | -$0.20 | -$0.21 | -0.01 | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$0.20 | -$0.21 | -0.01 | N/A | $0 |
| 08/08/2023 | Q2 2023 | -$0.49 | -$0.45 | 0.04 | N/A | $0 |
| 05/09/2023 | Q1 2023 | -$0.55 | -$0.52 | 0.03 | N/A | $0 |
| 03/17/2023 | Q4 2022 | -$0.62 | -$0.61 | 0.01 | N/A | $0 |
| 11/03/2022 | Q3 2022 | -$0.66 | -$0.69 | -0.03 | N/A | $0 |
| 08/09/2022 | Q2 2022 | -$0.67 | -$0.77 | -0.1 | N/A | $0 |
| 05/10/2022 | Q1 2022 | -$0.77 | -$0.81 | -0.04 | N/A | $0 |
| 03/03/2022 | Q4 2021 | -$0.74 | -$0.74 | 0 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.78 | -$0.80 | -0.02 | N/A | $0 |
| 08/09/2021 | Q2 2021 | -$0.77 | -$0.80 | -0.03 | N/A | $0 |
| 05/06/2021 | Q1 2021 | -$0.80 | -$0.78 | 0.02 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Gossamer Bio Inc Earnings: FAQ's
The conference call for Gossamer Bio Inc's latest earnings report can be listened to online.
The conference call transcript for Gossamer Bio Inc's latest earnings report can be read online.
Gossamer Bio Inc (:GOSS) has a recorded annual revenue of $48.47 M.
Gossamer Bio Inc (:GOSS) has a recorded net income of $-170,370,000.Gossamer Bio Inc has generated $-0.75 earnings per share over the last four quarters.
Gossamer Bio Inc (:GOSS) has a price-to-earnings ratio of -0.46 and price/earnings-to-growth ratio is 0.